Diabetes drug study reveals hidden genetic links to weight and inflammation
Disease control
Completed
This completed study looked at how two common diabetes drugs, dapagliflozin and empagliflozin, affect weight, cholesterol, and inflammation in 260 obese adults newly diagnosed with type 2 diabetes. Over six months, researchers measured changes in body weight, blood fats, and mark…
Phase: PHASE4 • Sponsor: Erbil Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC